Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.84 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.84 |
| ▸ | CYP1A1 | P04798 | 3/20 | 0.84 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.84 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.84 |
| ▸ | XDH | P47989 | 2/20 | 0.84 |
| ▸ | IPMK | Q8NFU5 | 2/20 | 0.84 |
| ▸ | IP6K2 | Q9UHH9 | 2/20 | 0.84 |
| ▸ | CA12 | O43570 | 1/20 | 0.84 |
| ▸ | CA2 | P00918 | 1/20 | 0.84 |
| ▸ | CA4 | P22748 | 1/20 | 0.84 |
| ▸ | PPARG | P37231 | 1/20 | 0.84 |
| ▸ | CA7 | P43166 | 1/20 | 0.84 |
| ▸ | DPP4 | P27487 | 1/20 | 0.82 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.82 |
| ▸ | LMNA | P02545 | 3/20 | 0.82 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.82 |
| ▸ | MAPT | P10636 | 3/20 | 0.82 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.82 |
| ▸ | APP | P05067 | 1/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Rhamnazin SCHEMBL39443 | 1.00 | MEN1 (0.84) | MEN1KMT2ACYP1A1CYP1A2CYP1B1 | |
| SCHEMBL1250547 | 0.93 | XDH (0.86) | MEN1KMT2ACYP1A1CYP1A2CYP1B1 | |
| Isorhamnetin SCHEMBL29377152 | 0.91 | MEN1 (1.00) | MEN1KMT2ACYP1A1CYP1A2CYP1B1 | |
| Isorhamnetin SCHEMBL29390102 | 0.91 | MEN1 (1.00) | MEN1KMT2ACYP1A1CYP1A2CYP1B1 | |
| Isorhamnetin SCHEMBL30385934 | 0.91 | MEN1 (1.00) | MEN1KMT2ACYP1A1CYP1A2CYP1B1 | |
| Isorhamnetin SCHEMBL19235 | 0.91 | MEN1 (1.00) | MEN1KMT2ACYP1A1CYP1A2CYP1B1 | |
| Ombuine SCHEMBL1252211 | 0.90 | XDH (1.00) | MEN1KMT2ACYP1A1CYP1A2CYP1B1 | |
| Ombuine SCHEMBL29475881 | 0.90 | XDH (1.00) | MEN1KMT2ACYP1A1CYP1A2CYP1B1 | |
| Ombuine SCHEMBL31516400 | 0.90 | XDH (1.00) | MEN1KMT2ACYP1A1CYP1A2CYP1B1 | |
| Rhamnetin SCHEMBL7164573 | 0.90 | MEN1 (1.00) | MEN1KMT2ACYP1A1CYP1A2CYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023064318-A1 | BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE | Natural Extraction Systems, LLC (US) | 2023-04-20 | — | — | WO | claimed |
| CN-114642695-A | Big data traditional Chinese medicine composition for regulating and controlling prostate cancer | 华子昂 | 2022-06-21 | — | — | CN | claimed |
| CN-122055354-A | Lipid compounds and related compositions and uses | 波西达治疗公司 | 2026-05-15 | — | — | CN | disclosed |
| WO-2025038482-A2 | USE OF FISETIN FOR REDUCING THE INCIDENCE OF ATRIAL FIBRILLATION | RHODE ISLAND HOSPITAL (US) | 2025-02-20 | — | — | WO | disclosed |
| US-20240293600-A1 | COMPOSITIONS, METHODS, AND DEVICES FOR SUSTAINED RELEASE OF AN AGENT | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE | 2024-09-05 | — | — | US | disclosed |
| US-12053441-B2 | Formulations for improving the delivery of hydrophobic agents | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) | 2024-08-06 | — | — | US | disclosed |
| EP-4359026-A1 | COMPOSITIONS, METHODS, AND DEVICES FOR SUSTAINED RELEASE OF AN AGENT | Board of Supervisors of Louisiana State University and Agricultural and Mechanical College (US) | 2024-05-01 | — | — | EP | disclosed |
| WO-2023064318-A1 | BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE | Natural Extraction Systems, LLC (US) | 2023-04-20 | — | — | WO | disclosed |
| WO-2022272243-A1 | COMPOSITIONS, METHODS, AND DEVICES FOR SUSTAINED RELEASE OF AN AGENT | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2022-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12053441-B2 | Formulations for improving the delivery of hydrophobic agents | COQ8A, COQ8B, NDUFAB1 | MEN1 3151/4885KMT2A 3880/4885CYP1A1 2136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.